Author:
Nishimura Kazuo,Nonomura Norio,Hashine Katsuyoshi,Kanayama Hiro-omi,Ozono Seiichiro,Miura Takeshi,Miki Tsuneharu,Kakehi Yoshiyuki,Arai Yoichi,Ogawa Osamu,Fujita Ryuji,Nonomura Katsuya,Mizokami Atsushi,Hoshi Senji,Akaza Hideyuki
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference19 articles.
1. American Cancer Society (2010). Detailed guide: prostate cancer 2009. What are the key statistics about prostate cancer? http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_prostate_cancer_36.asp?sitearea of subordinate document. Accessed March 2011
2. Ministry of Health, Labor and Welfare (2011) Vital statistics in Japan—the latest trends, p 18. http://www.mhlw.go.jp/english/database/db-hw/dl/81-1a2en.pdf of subordinate document. Accessed March 2011
3. Suzuki K (2009) Epidemiology of prostate cancer and benign prostatic hyperplasia. JMAJ 52:478–483. http://www.med.or.jp/english/journal/pdf/2009_06/478_483.pdf of subordinate document
4. Ringel I, Horwitz SB (1991) Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 83:288–291
5. Tannock IF, de Wit R, Berry WR et al (2004) Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 351:1502–1512
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献